跳转至内容
Merck
CN
  • Impending corneal perforation after collagen cross-linking for herpetic keratitis.

Impending corneal perforation after collagen cross-linking for herpetic keratitis.

Journal of cataract and refractive surgery (2013-03-26)
Giulio Ferrari, Lorenzo Iuliano, Maurizia Viganò, Paolo Rama
摘要

Collagen crosslinking (CXL) has been proposed as a treatment for infectious keratitis. Given the insurgence of antibiotic-resistant microorganisms and frequent toxicity of topical medications, CXL may be a potential treatment for corneal infections. However, corneal infection is itself a possible complication of this treatment. We describe a case of severe corneal thinning and melting in a woman who had a CXL procedure as a treatment for herpetic keratitis.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
(−)-核黄素, from Eremothecium ashbyii, ≥98%
Sigma-Aldrich
(−)-核黄素, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Supelco
核黄素 (B2), analytical standard
Supelco
核黄素, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(−)-核黄素, meets USP testing specifications
Supelco
阿昔洛韦, Pharmaceutical Secondary Standard; Certified Reference Material
核黄素, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
阿昔洛韦, ≥99% (HPLC), powder
阿昔洛韦, European Pharmacopoeia (EP) Reference Standard